Cargando…

Risk assessment of failure during transitioning from in-centre to home haemodialysis

BACKGROUND: Introducing a de-novo home haemodialysis (HHD) program often raises safety concerns as errors could potentially lead to serious adverse events. Despite the complexity of performing haemodialysis at home without the supervision of healthcare staff, HHD has a good safety record. We aim to...

Descripción completa

Detalles Bibliográficos
Autores principales: Haroon, Sabrina-Wong-Peixin, Lau, Titus-Wai-Leong, Tan, Gan Liang, Liu, Eugene-Hern Choon, Hui, Soh Heng, Lim, Siao Luan, Santos, Diana, Hodgson, Robyn, Taylor, Lindsay, Tan, Jia Neng, Davenport, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768953/
https://www.ncbi.nlm.nih.gov/pubmed/36539703
http://dx.doi.org/10.1186/s12882-022-03039-4
_version_ 1784854282170793984
author Haroon, Sabrina-Wong-Peixin
Lau, Titus-Wai-Leong
Tan, Gan Liang
Liu, Eugene-Hern Choon
Hui, Soh Heng
Lim, Siao Luan
Santos, Diana
Hodgson, Robyn
Taylor, Lindsay
Tan, Jia Neng
Davenport, Andrew
author_facet Haroon, Sabrina-Wong-Peixin
Lau, Titus-Wai-Leong
Tan, Gan Liang
Liu, Eugene-Hern Choon
Hui, Soh Heng
Lim, Siao Luan
Santos, Diana
Hodgson, Robyn
Taylor, Lindsay
Tan, Jia Neng
Davenport, Andrew
author_sort Haroon, Sabrina-Wong-Peixin
collection PubMed
description BACKGROUND: Introducing a de-novo home haemodialysis (HHD) program often raises safety concerns as errors could potentially lead to serious adverse events. Despite the complexity of performing haemodialysis at home without the supervision of healthcare staff, HHD has a good safety record. We aim to pre-emptively identify and reduce the risks to our new HHD program by risk assessment and using failure mode and effects analysis (FMEA) to identify potential defects in the design and planning of HHD. METHODS: We performed a general risk assessment of failure during transitioning from in-centre to HHD with a failure mode and effects analysis focused on the highest areas of failure. We collaborated with key team members from a well-established HHD program and one HHD patient. Risk assessment was conducted separately and then through video conference meetings for joint deliberation. We listed all key processes, sub-processes, step and then identified failure mode by scoring based on risk priority numbers. Solutions were then designed to eliminate and mitigate risk. RESULTS: Transitioning to HHD was found to have the highest risk of failure with 3 main processes and 34 steps. We identified a total of 59 areas with potential failures. The median and mean risk priority number (RPN) scores from failure mode effect analysis were 5 and 38, with the highest RPN related to vascular access at 256. As many failure modes with high RPN scores were related to vascular access, we focussed on FMEA by identifying the risk mitigation strategies and possible solutions in all 9 areas in access-related medical emergencies in a bundled- approach. We discussed, the risk reduction areas of setting up HHD and how to address incidents that occurred and those not preventable. CONCLUSIONS: We developed a safety framework for a de-novo HHD program by performing FMEA in high-risk areas. The involvement of two teams with different clinical experience for HHD allowed us to successfully pre-emptively identify risks and develop solutions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-03039-4.
format Online
Article
Text
id pubmed-9768953
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97689532022-12-22 Risk assessment of failure during transitioning from in-centre to home haemodialysis Haroon, Sabrina-Wong-Peixin Lau, Titus-Wai-Leong Tan, Gan Liang Liu, Eugene-Hern Choon Hui, Soh Heng Lim, Siao Luan Santos, Diana Hodgson, Robyn Taylor, Lindsay Tan, Jia Neng Davenport, Andrew BMC Nephrol Research BACKGROUND: Introducing a de-novo home haemodialysis (HHD) program often raises safety concerns as errors could potentially lead to serious adverse events. Despite the complexity of performing haemodialysis at home without the supervision of healthcare staff, HHD has a good safety record. We aim to pre-emptively identify and reduce the risks to our new HHD program by risk assessment and using failure mode and effects analysis (FMEA) to identify potential defects in the design and planning of HHD. METHODS: We performed a general risk assessment of failure during transitioning from in-centre to HHD with a failure mode and effects analysis focused on the highest areas of failure. We collaborated with key team members from a well-established HHD program and one HHD patient. Risk assessment was conducted separately and then through video conference meetings for joint deliberation. We listed all key processes, sub-processes, step and then identified failure mode by scoring based on risk priority numbers. Solutions were then designed to eliminate and mitigate risk. RESULTS: Transitioning to HHD was found to have the highest risk of failure with 3 main processes and 34 steps. We identified a total of 59 areas with potential failures. The median and mean risk priority number (RPN) scores from failure mode effect analysis were 5 and 38, with the highest RPN related to vascular access at 256. As many failure modes with high RPN scores were related to vascular access, we focussed on FMEA by identifying the risk mitigation strategies and possible solutions in all 9 areas in access-related medical emergencies in a bundled- approach. We discussed, the risk reduction areas of setting up HHD and how to address incidents that occurred and those not preventable. CONCLUSIONS: We developed a safety framework for a de-novo HHD program by performing FMEA in high-risk areas. The involvement of two teams with different clinical experience for HHD allowed us to successfully pre-emptively identify risks and develop solutions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-03039-4. BioMed Central 2022-12-20 /pmc/articles/PMC9768953/ /pubmed/36539703 http://dx.doi.org/10.1186/s12882-022-03039-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Haroon, Sabrina-Wong-Peixin
Lau, Titus-Wai-Leong
Tan, Gan Liang
Liu, Eugene-Hern Choon
Hui, Soh Heng
Lim, Siao Luan
Santos, Diana
Hodgson, Robyn
Taylor, Lindsay
Tan, Jia Neng
Davenport, Andrew
Risk assessment of failure during transitioning from in-centre to home haemodialysis
title Risk assessment of failure during transitioning from in-centre to home haemodialysis
title_full Risk assessment of failure during transitioning from in-centre to home haemodialysis
title_fullStr Risk assessment of failure during transitioning from in-centre to home haemodialysis
title_full_unstemmed Risk assessment of failure during transitioning from in-centre to home haemodialysis
title_short Risk assessment of failure during transitioning from in-centre to home haemodialysis
title_sort risk assessment of failure during transitioning from in-centre to home haemodialysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768953/
https://www.ncbi.nlm.nih.gov/pubmed/36539703
http://dx.doi.org/10.1186/s12882-022-03039-4
work_keys_str_mv AT haroonsabrinawongpeixin riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT lautituswaileong riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT tanganliang riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT liueugenehernchoon riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT huisohheng riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT limsiaoluan riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT santosdiana riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT hodgsonrobyn riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT taylorlindsay riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT tanjianeng riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis
AT davenportandrew riskassessmentoffailureduringtransitioningfromincentretohomehaemodialysis